Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LFCRLFCR
25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LIFECORE BIOMEDICAL INC

CITADEL ADVISORS LLC holds 98,870 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $519,067 as of 2026-Q2. This is a new position. LFCR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$519,067

Current Shares

98,870

Total Value Change

+$408,067

Total Shares Change

+87,014

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
98,870
-
$519,0670.0%$5.25
33
2026-Q1
Exited
0
-100.0%
$00.0%$6.99
0
2025-Q4
Decreased
18,116
-72.9%
$148,1890.0%$8.09
0
2025-Q3
Increased
66,752
+127.1%
$491,2950.0%$7.15
39
2025-Q2
Decreased
29,389
-3.7%
$238,6390.0%$8.19
0
2025-Q1
New
30,523
-
$214,8820.0%$6.85
35
2024-Q3
Exited
0
-100.0%
$00.0%$4.95
0
2024-Q2
New
42,437
-
$217,7020.0%$5.13
35
2023-Q4
Exited
0
-100.0%
$00.0%$6.19
0
2023-Q3
Increased
75,321
+10.1%
$568,2970.0%$7.55
27
2023-Q2
New
68,406
-
$661,4860.0%$9.84
34
2023-Q1
Exited
0
-100.0%
$00.0%$3.79
0
2022-Q4
New
83,755
-
$542,7330.0%$6.48
34
2022-Q3
Exited
0
-100.0%
$00.0%$8.89
0
2022-Q2
Decreased
17,539
-61.8%
$175,0000.0%$10.06
0
2022-Q1
New
45,860
-
$531,0000.0%$11.42
34
2021-Q3
Exited
0
-100.0%
$00.0%$10.28
0
2021-Q2
Decreased
50,102
-17.4%
$564,0000.0%$10.95
0
2021-Q1
Increased
60,628
+3.1%
$643,0000.0%$10.55
25
2020-Q4
New
58,795
-
$638,0000.0%$10.60
34
2020-Q2
Exited
0
-100.0%
$00.0%$9.80
0
2020-Q1
Increased
23,340
+76.1%
$203,0000.0%$8.47
35
2019-Q4
Decreased
13,255
-27.5%
$150,0000.0%$11.17
0
2019-Q3
Increased
18,272
+54.1%
$199,0000.0%$10.65
32
2019-Q2
New
11,856
-
$111,0000.0%$9.37
30

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used